Sanjin Pharmaceutical IPO today won the first restart will be listed on a single small plate

 Source: Shanghai Securities News
IPO today won the first restart Sanjin Pharmaceutical Pharmaceutical single
three gold does not exceed 4,600 shares to be issued under the net under the net issue of 20% of the online released June 29 are listed Small plates
One year ago today, Sanjin Pharmaceutical announced pre-IPO disclosure documents; year later, Sanjin Pharmaceutical be suspended IPO set sail again after 9 months of the first single.
three gold Pharmaceutical prospectus disclosed today show that the company intends to release no more than 4600 million new shares, representing the total share capital after the release of 45,400 shares at no more than 10.14%, will be prioritized in order to raise funds to invest in 10 projects with a total investment of 634.12 million yuan, the company will be based on market conditions and the inquiry to determine the final funding amount will be issued after the company traded in small plates, stock code 002275.
market that, IPO preferred choice of small plates to restart the company, showing that the regulatory floor care market.
arranged according to sponsor China Merchants Securities, issued by Sanjin Pharmaceutical inquiry objects to the inquiry under the net placing subscription pricing and online distribution of funds combined manner, the network is not more than 9.2 million issued under shares, representing 20% of the offering amount. net in time for release June 29 9:30-15:00, online issue of time for June 29 trading hours.
22, 23, 24 , China Merchants Securities will be held in Beijing, Shanghai, Shenzhen Securities Association of China announced to the inquiry objects roadshow.
Sanjin Pharmaceutical prospectus shows that the last three years the company's net profit attributable to equity shareholders of the respective to 194.8 million yuan, 249.17 million yuan and 273.72 million yuan and earnings per share were 0.48 yuan, 0.61 yuan and 0.67 yuan, fully diluted net assets were 31%, 34% and 35%.
this issue shares before, Zou Ming Festival held directly Sanjin Pharmaceutical 10.07% stake, through its own direct and indirect total and relatives held Sanjin Pharmaceutical 44.53% stake in the company's actual controller, also served as chairman.
It is understood that the three King Pharmaceutical in June 19, 2008 declaration of disclosure of the prospectus is issued, June 23, 2008 through the issuance examination committee for review. by the time off will be sorted, Sanjin Pharmaceutical is not IPO would have been the third company, preceded by Chinese architecture and Zunyi Titanium.
Sanjin Pharmaceutical prospectus, which means A suspension of 9 months of the IPO shares had finally set sail again.
since last Sept. 5 after the IPO Huachang Chemical, and issuing new shares due to market reforms and other reasons, starting financing project has been shelved. June 10 this year, the CSRC issued the Shenzhen Stock Exchange China Securities Depository and Clearing Corporation shares issued revised online and rules issued under the afternoon, won three gold Pharmaceutical IPO China Securities Regulatory Commission's approval.